Sharpe ratio
0.28Return earned for the risk taken.
Moderate
Moderate risk-adjusted returns. The reward for risk has been average.
+16.62%1Y Absolute Return
-0.26%1D
Loading NAV history…
Past performance is not an indicator of future returns.
Returns calculator comparison
Compare an illustrative investment outcome across return assumptions.
| Asset | Projected corpus | Total invested | Gain | Annual return |
|---|---|---|---|---|
| Baroda BNP Paribas Health and Wellness Fund Direct GrowthFund 1Y annualised return · 5Y history unavailable | ₹11,11,053 | ₹7,32,612 | ₹3,78,441 | +16.62% |
| EPFIllustrative annual assumption | ₹8,95,132 | ₹7,32,612 | ₹1,62,520 | +8.25% |
| Residential propertyIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| PPFIllustrative annual assumption | ₹8,69,819 | ₹7,32,612 | ₹1,37,207 | +7.10% |
| Bank fixed depositIllustrative annual assumption | ₹8,56,981 | ₹7,32,612 | ₹1,24,369 | +6.50% |
| GoldIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| Savings accountIllustrative annual assumption | ₹7,86,827 | ₹7,32,612 | ₹54,215 | +3.00% |
Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.
Wealth multiple
₹1 became₹1.09
₹1 Lakh since launch₹1.09 Lakh
Fund age1.4 yrs
Fund information
Scheme code153604
ISININF251K01VA5
BenchmarkBSE Healthcare TRI
CategoryEquity Scheme - Sectoral/ Thematic
Expense ratio1.51%
Exit loadExit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
Minimum SIP₹500 SIP
Return comparison
121st / 932 in category| Period | Fund | Benchmark | Category avg |
|---|---|---|---|
| 1M | +179.21% | — | — |
| 3M | +15.77% | — | — |
| 6M | +25.22% | — | — |
| 1Y | +16.62% | — | +4.16% |
| Since Launch | +9.33% | — | — |
Risk-adjusted performance
Every measure is expanded with a plain-language reading of the latest calculated value.
Sortino ratio
0.41Return earned while limiting downside risk.
Moderate
Moderate downside risk-adjusted performance.
Standard deviation
12.70%How much the fund’s returns fluctuate over time.
Moderate volatility
Returns can move up and down noticeably.
Beta
—How closely the fund moves with the market.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Alpha
—Extra return generated above the benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Treynor ratio
—Return earned for each unit of market risk taken.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Calmar ratio
0.84How well the fund rewarded investors relative to its biggest decline.
Good
Good return relative to the drawdowns experienced.
Information ratio
—How consistently the fund outperformed its benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Portfolio allocation
Latest disclosed portfolio mix
Asset allocation
Allocation data has not been disclosed.
Market cap allocation
Sector allocation
Equity exposure by sector
Top holdings
10 of 32 disclosed positions
| Holding | Sector | Instrument type | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.82% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 8.58% |
| Divi's Laboratories Ltd | Healthcare | Equity | 6.66% |
| Lupin Ltd | Healthcare | Equity | 6.46% |
| Ipca Laboratories Ltd | Healthcare | Equity | 5.72% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.35% |
| Laurus Labs Ltd | Healthcare | Equity | 5.24% |
| Fortis Healthcare Ltd | Healthcare | Equity | 4.55% |
| Astrazeneca Pharma India Ltd | Healthcare | Equity | 4.05% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 3.44% |
Fund management
RO
Rohan Korde
Since 2026 · Prior to joining Baroda BNP Paribas Mutual Fund, he has worked with ITI Mutual Fund, BOB Capital Markets as Vice President
Mr. Korde is a Masters in Management Studies (Finance), Bachelor of Commerce
AN
Ankeet Pandya
Since 2026 · Prior to joining Baroda BNP Paribas Mutual Fund, he was working with InCred Asset management Private Ltd, Motilal Oswal Securities Ltd and Elara Capital India Private Ltd.
MBA Finance
Compare similar funds
No comparable category funds are available yet.
Summary
A very high-risk equity scheme - sectoral/ thematic fund. Losses and swings stayed contained — worst fall -11.1%, volatility 12.7%. Healthcare makes up 93% — trouble in that sector hits the whole fund.
Strengths
- Losses and swings stayed contained — worst fall -11.1%, volatility 12.7%.
- Recovered from its worst fall in 4 months.
- Ranks 121 of 932 in its category over 1 year.
Weaknesses
- None
Ideal investor
- Needs a 5–7+ years horizon to ride out its very high risk level.
- Good fit for SIPs — spreading purchases smooths out 12.7% volatility.
Risk drivers
- Healthcare makes up 93% — trouble in that sector hits the whole fund.